Market Opportunities-arkiv - Biosector Ltd.

by Stefan Sandström

Infographic: Organoids and Organs-On-Chips

0

by Stefan Sandström

Takeda’s Savings Spree: What the Restructuring Really Means Now

Takeda’s savings programme is no longer an abstract investor slide. It has moved from corporate language […]

0

by Stefan Sandström

Takeda’s JPY 200 Billion Pivot: Welcome to Takeda’s New Launch Machine

The JPY 200 billion savings target currently dominating Takeda’s internal dialogue isn’t just a number on […]

1

by Stefan Sandström

Where the Organoid Field Stands Today

0

by Stefan Sandström

Infographic: Why CNS is the next Battleground for Organoids

0

Business executive overlooking Japan’s pharmaceutical opportunity, with Mount Fuji, Tokyo skyline, Shinkansen, laboratory scientists, DNA helix, medicine vials, and an upward growth graph.

by Stefan Sandström

Catching Pharmaceutical Opportunities in Japan’s Reinvented Pharmaceutical Arena

For too long, if you ask me, the Japan pharmaceutical market opportunity has been treated as […]

0

Wide Biosector infographic showing five human-relevant model systems in drug discovery: spheroids, organoids, assembloids, organ-on-a-chip, and multi-organ systems, arranged from lower complexity to stronger translational insight.

by Stefan Sandström

Organoids, Organs-on-Chips, and the End of Lazy Translation

This article is a run-through of organoids and organs-on-chips in drug discovery! Drug discovery has a […]

0

A side-by-side comparison of a Japanese tradeshow. The left panel, labeled "THEN," is rendered in dull grey-brown tones and shows exhausted, confused professionals wandering a crowded, chaotic expo floor, staring at maps and phones. The right panel, labeled "SOON," is vibrant and modern, showing happy professionals in formal suits and dresses engaging in focused, productive meetings and exchanging business cards in a well-organized, high-signal event space.

by Stefan Sandström

AI-Powered Events: The Future of Data-Driven Connection and High-Signal Events

Let’s be brutally honest: the traditional event experience is fundamentally broken. It is a relic of […]

0

Abstract wide illustration showing Japan drug pricing from listing to post-launch revisions, using blue shapes on a sand background with red trigger markers.

by Stefan Sandström

December 15, 2025

Japan FY2026 Drug Pricing Reform Draft: What Changes at Listing, What Tightens After Launch

On December 12, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) tabled a draft outline […]

0

Photorealistic scene of a consultant in a Tokyo meeting room connecting a foreign company with Japanese pharma executives.

by Stefan Sandström

December 11, 2025

Why Japanese Targets Like You, Listen to You – and Still You Don’t Succeed

You fly in, you present, you charm the room. Heads nod. The technical team likes your […]

0